Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2027, 2028, and 2029
Funds translational cancer research programmes — several linked projects on one organ-specific cancer or a related group — reaching a human endpoint.
Basic cancer biology and an actual improvement in prevention, detection or treatment are two different things, and a lot of promising science never crosses that gap.
SPORE funds a translational research programme built around one organ-specific cancer, or a small group of highly related cancers. A related group can share an organ system — gastrointestinal, neuroendocrine, head and neck and others…
State-of-the-art, investigator-initiated translational research programmes on an organ-specific cancer or a highly related group of cancers, sharing an organ system, a common biological mechanism, or a cross-cutting theme such as paediatric cancer or epigenetics, using cellular, molecular, structural, biochemical or genetic methods and aimed at a translational human endpoint within the project period. A clinical trial is required.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see how they score you
Sign up free to see the timeline
Sign up free to see where teams trip up